Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;39(12):926-928.
doi: 10.1051/medsci/2023169. Epub 2023 Dec 18.

[Prediction of homologous recombination status with deep learning on breast cancer whole slide images]

[Article in French]
Tristan Lazard  1 , Guillaume Bataillon  2 , Thomas Walter  1 , Anne Vincent Salomon  3
Affiliations
Free article

[Prediction of homologous recombination status with deep learning on breast cancer whole slide images]

[Article in French]
Tristan Lazard et al. Med Sci (Paris). 2023 Dec.
Free article
No abstract available

PubMed Disclaimer

References

    1. Bryant HE, Schultz N, Thomas HD, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005 ; 434 : 913–917.
    1. Farmer H, McCabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005 ; 434 : 917–921.
    1. Tung NM, Robson ME, Ventz S, et al. TBCRC 048: Phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes. J Clin Oncol 2020; 38 : 4274–82.
    1. Tutt ANJ, Garber JE, Kaufman B, et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med 2021; 384 : 2394–2405.
    1. Popova T, Manie E, Rieunier G, et al. Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation. Cancer Res 2012 ; 72 : 5454–5462.

LinkOut - more resources